Cargando…
Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate
Shigellosis is common worldwide, and it causes significant morbidity and mortality mainly in young children in low- and middle- income countries. To date, there are not broadly available licensed Shigella vaccines. A novel type of conjugate vaccine candidate, SF2a-TT15, was developed against S. flex...
Autores principales: | Toapanta, Franklin R., Hu, Jingping, Meron-Sudai, Shiri, Mulard, Laurence A., Phalipon, Armelle, Cohen, Dani, Sztein, Marcelo B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653583/ https://www.ncbi.nlm.nih.gov/pubmed/38022674 http://dx.doi.org/10.3389/fimmu.2023.1291664 |
Ejemplares similares
-
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
por: Meron-Sudai, Shiri, et al.
Publicado: (2023) -
Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens
por: Kunstmann, Sonja, et al.
Publicado: (2018) -
Dipstick for Rapid Diagnosis of Shigella flexneri 2a in Stool
por: Nato, Faridabano, et al.
Publicado: (2007) -
Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges
por: Phalipon, Armelle, et al.
Publicado: (2022) -
Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022)